Moderna Announces First Participant Dosed in Phase 1 Study of its HIV Trimer mRNA Vaccine - Stockhouse
3/14/2022 12:00:00 AM3 years 1 month ago
by Stockhouse.com
by Stockhouse.com
Moderna Announces First Participant Dosed in Phase 1 Study of its HIV Trimer mRNA Vaccine
CAMBRIDGE, MA / ACCESSWIRE / March 14, 2022 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participan… [+6390 chars]
full article...